Evidence map›Paper›PMID 25135940›Full record

ArticleeLife2014

mRNA-programmed translation pauses in the targeting of E. coli membrane proteins.

Nir Fluman, Sivan Navon, Eitan Bibi, Yitzhak Pilpel

Open access · goldAbstract read
In one paragraph

Article in eLife, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Spatiotemporal kinetics of the SRP pathway in liveProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. The effects of codon bias and optimality on mRNA and protein regulation.Cellular and molecular life sciences : CMLS · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Translation elongation factor P (EF-P).FEMS microbiology reviews · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Archaeal cell surface biogenesis.FEMS microbiology reviews · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nir FlumanDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Sivan NavonDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Eitan BibiDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Yitzhak PilpelDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In all living organisms, ribosomes translating membrane proteins are targeted to membrane translocons early in translation, by the ubiquitous signal recognition particle (SRP) system. In eukaryotes, the SRP Alu domain arrests translation elongation of membrane proteins until targeting is complete. Curiously, however, the Alu domain is lacking in most eubacteria. In this study, by analyzing genome-wide data on translation rates, we identified a potential compensatory mechanism in E. coli that serves to slow down the translation during membrane protein targeting. The underlying mechanism is likely programmed into the coding sequence, where Shine-Dalgarno-like elements trigger elongation pauses at strategic positions during the early stages of translation. We provide experimental evidence that slow translation during targeting and improves membrane protein production fidelity, as it correlates with better folding of overexpressed membrane proteins. Thus, slow elongation is important for membrane protein targeting in E. coli, which utilizes mechanisms different from the eukaryotic one to control the translation speed.

Indexed as

Gene Expression Regulation, BacterialProtein BiosynthesisBacillus subtilisCell MembraneCodonEscherichia coliEscherichia coli ProteinsMembrane ProteinsMutagenesisProtein Structure, TertiaryProtein TransportRibosomesSignal Recognition ParticleCodonEscherichia coli ProteinsMembrane ProteinsSignal Recognition ParticleB. subtiliscell biologyE. colievolutionary biologygenomicsmembrane proteinsquality controltranslation rate

Identifiers

PMID25135940
PMCPMC4359368
OpenAlexW2148414397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.